Fotemustine Plus Etoposide, Cytarabine and Melphalan (FEAM) as a New Conditioning Regimen for Lymphoma Patients Undergoing Auto-Sct: A Multicenter Feasibility Study
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2009.318
Full Text
Open PDFAbstract
Available in full text
Date
November 9, 2009
Authors
Publisher
Springer Science and Business Media LLC